MIF and metastatic neoplasm: Indeed, analysis performed by Oliveira et al. [23] showed that MIF expression levels were not associated with patient outcome in primary melanoma, but higher MIF levels were correlated with faster disease recurrence in metastatic disease [24], correlating with the results of the Ekmekcioglu study [24].